Data analysis
IVF in the US: patients face total costs of $24,000–$72,000 to have a baby, with limited insurance coverage
Published 15 April 2026 · TreatCompare US
A typical US couple paying out-of-pocket will spend an estimated $48,000 across an average of 2 cycles to achieve one live birth — equivalent to 64% of US median household income. 30 of 51 states and the District of Columbia provide no IVF insurance mandate whatsoever, and even in the 21 that do, federal ERISA preemption excludes the self-insured employer plans covering roughly 60% of workers.
Key findings
- ● Average IVF cycle cost: $12,000–$20,000 base, plus $3,000–$7,000 medication and $2,000–$10,000 in add-ons when used
- ● Typical total cost to one live birth: $24,000–$72,000, headline estimate $48,000 (at 2 cycles)
- ● 59% of US jurisdictions (30 of 51) provide no state-mandated IVF insurance coverage
- ● IVF costs equivalent to 64% of US median household income ($75,149)
- ● Coverage varies dramatically: affordability ratio ranges from 20% in New Hampshire to 83% in Mississippi
- ● Medical tourism can save up to 73%: two cycles in Czech Republic plus travel total $13,120 versus $48,000 in the US
1. The true cost of IVF
The sticker price of an IVF cycle understates what patients actually spend. A “cycle” in clinic marketing typically refers to the base procedure — monitoring, egg retrieval, fertilisation, embryo culture, and one fresh transfer. Three categories of cost are almost always billed separately:
- Stimulation medication ($3,000–$7,000): dispensed by specialty pharmacies, not the clinic. Insurance coverage for fertility medication is weaker than for procedures.
- Add-ons ($2,000–$10,000 if used): ICSI (single-sperm injection), PGT (preimplantation genetic testing), embryo cryopreservation, assisted hatching. The majority of US clinics now use PGT on more than half of transfers, and ICSI is standard for any male-factor case.
- Multiple cycles: CDC data show that under age 35 a typical patient needs ~2 intended retrievals to achieve one live birth; that rises sharply with age (3+ at 38–40, 8+ over 40). Plans for one cycle are almost always plans for two.
The typical budget for one live birth under current US pricing, combining all three categories at national averages and assuming 2 cycles: $48,000. Budget-conservative single-cycle success: $24,000. Worst case 3 cycles with add-ons: $72,000.
2. The insurance coverage gap
21 of 51 US jurisdictions require insurers to cover some form of IVF. That headline hides material variation.
Only 6 states (Massachusetts, New Hampshire, New York, Colorado, Delaware, and the District of Columbia) have what we classify as a full mandate — covering oocyte retrievals and unlimited transfers without a low cycle cap or narrowing condition. Others have partial mandates with hard caps: Arkansas stops at a $15,000 lifetime maximum, Rhode Island at $100,000, Connecticut at 2 cycles, Illinois at 4 retrievals. Still others (Texas, Louisiana, Montana, Ohio, West Virginia) have “must-offer” or “diagnostic-only” mandates that in practice leave most patients self-paying.
The larger exclusion is federal: ERISA preemption exempts self-insured employer health plans from any state insurance mandate. Roughly 60% of US workers with employer coverage are in self-insured plans. A patient with a “mandate” on paper may have no protection in practice, simply because their employer chose to self-insure.
Modelled out-of-pocket share by mandate type: full mandate 35%, partial 70%, must-offer 90%, diagnostic-only 100%, no mandate 100%. ERISA self-insured plans default to 100% regardless of state mandate. These assumptions drive the affordability ratios below.
3. Affordability by state
Combining modelled out-of-pocket cost with state median household income produces an affordability ratio. A ratio of 50% means paying for IVF costs half of a household’s annual median income before tax. In Mississippi the ratio exceeds 83%; in New Hampshire it is under 20%. This is the US fertility postcode lottery.
5 most affordable states
| State | Median income | Modelled OOP | Ratio (% of income) | Mandate |
|---|---|---|---|---|
| New Hampshire | $90,845 | $17,819 | 20% | Yes |
| Colorado | $87,598 | $17,300 | 20% | Yes |
| Illinois | $78,433 | $16,026 | 20% | Yes |
| District of Columbia | $101,027 | $21,347 | 21% | Yes |
| Delaware | $79,325 | $16,908 | 21% | Yes |
5 least affordable states
| State | Median income | Modelled OOP | Ratio (% of income) | Mandate |
|---|---|---|---|---|
| Mississippi | $52,985 | $43,940 | 83% | None |
| West Virginia | $55,948 | $44,556 | 80% | Yes |
| Louisiana | $57,852 | $45,480 | 79% | Yes |
| New Mexico | $58,722 | $45,676 | 78% | None |
| Kentucky | $60,183 | $45,760 | 76% | None |
See full affordability table, all 51 jurisdictions →
| State | Income | Modelled total | OOP | Ratio | Mandate |
|---|---|---|---|---|---|
| New Hampshire | $90,845 | $50,912 | $17,819 | 20% | Yes |
| Colorado | $87,598 | $49,428 | $17,300 | 20% | Yes |
| Illinois | $78,433 | $45,788 | $16,026 | 20% | Yes |
| District of Columbia | $101,027 | $60,992 | $21,347 | 21% | Yes |
| Delaware | $79,325 | $48,308 | $16,908 | 21% | Yes |
| Massachusetts | $96,505 | $61,020 | $21,357 | 22% | Yes |
| California | $91,905 | $58,780 | $20,573 | 22% | Yes |
| New York | $81,386 | $55,028 | $19,260 | 24% | Yes |
| Maryland | $98,461 | $52,620 | $36,834 | 37% | Yes |
| New Jersey | $96,346 | $51,696 | $36,187 | 38% | Yes |
| Utah | $86,833 | $47,860 | $33,502 | 39% | Yes |
| Connecticut | $90,213 | $51,668 | $36,168 | 40% | Yes |
| Rhode Island | $81,854 | $50,800 | $35,560 | 43% | Yes |
| Hawaii | $94,814 | $70,484 | $49,339 | 52% | Yes |
| Maine | $68,251 | $51,220 | $35,854 | 53% | Yes |
| Minnesota | $84,313 | $46,348 | $46,348 | 55% | No |
| Virginia | $87,249 | $48,392 | $48,392 | 55% | No |
| Arkansas | $55,432 | $44,612 | $31,228 | 56% | Yes |
| Texas | $73,035 | $45,956 | $41,360 | 57% | Yes |
| Washington | $90,325 | $51,276 | $51,276 | 57% | No |
| North Dakota | $73,959 | $46,460 | $46,460 | 63% | No |
| Wyoming | $72,495 | $45,872 | $45,872 | 63% | No |
| Kansas | $69,747 | $44,388 | $44,388 | 64% | No |
| Nebraska | $71,722 | $45,676 | $45,676 | 64% | No |
| Georgia | $71,355 | $45,508 | $45,508 | 64% | No |
| Pennsylvania | $73,170 | $46,768 | $46,768 | 64% | No |
| Iowa | $70,571 | $45,284 | $45,284 | 64% | No |
| Wisconsin | $72,458 | $46,628 | $46,628 | 64% | No |
| Alaska | $84,814 | $55,560 | $55,560 | 66% | No |
| South Dakota | $69,457 | $45,872 | $45,872 | 66% | No |
| Michigan | $68,505 | $45,368 | $45,368 | 66% | No |
| Nevada | $71,646 | $48,224 | $48,224 | 67% | No |
| Missouri | $65,920 | $44,612 | $44,612 | 68% | No |
| Indiana | $67,173 | $45,480 | $45,480 | 68% | No |
| Idaho | $70,214 | $47,608 | $47,608 | 68% | No |
| Oregon | $76,362 | $52,228 | $52,228 | 68% | No |
| Arizona | $72,581 | $50,100 | $50,100 | 69% | No |
| Ohio | $66,990 | $46,264 | $46,264 | 69% | Yes |
| North Carolina | $66,186 | $46,544 | $46,544 | 70% | No |
| Vermont | $74,014 | $52,060 | $52,060 | 70% | No |
| Montana | $66,341 | $46,712 | $46,712 | 70% | Yes |
| Tennessee | $64,035 | $45,284 | $45,284 | 71% | No |
| Oklahoma | $61,364 | $44,024 | $44,024 | 72% | No |
| Florida | $67,917 | $48,784 | $48,784 | 72% | No |
| South Carolina | $63,623 | $46,684 | $46,684 | 73% | No |
| Alabama | $59,673 | $44,612 | $44,612 | 75% | No |
| Kentucky | $60,183 | $45,760 | $45,760 | 76% | No |
| New Mexico | $58,722 | $45,676 | $45,676 | 78% | No |
| Louisiana | $57,852 | $45,480 | $45,480 | 79% | Yes |
| West Virginia | $55,948 | $44,556 | $44,556 | 80% | Yes |
| Mississippi | $52,985 | $43,940 | $43,940 | 83% | No |
4. Why US patients go abroad
For patients without insurance coverage, overseas IVF is not a fringe option. Modelling two cycles at the midpoint of each destination’s published ranges, plus $2,500 in travel costs, against a typical US out-of-pocket of $48,000:
| Destination | 2 cycles + travel (USD) | Savings vs US | % saved |
|---|---|---|---|
| Czech Republic Prague Fertility Centre · Reprofit International (Brno) | $13,120 | $34,880 | 73% |
| Greece Serum IVF (Athens) · Embryolab (Thessaloniki) | $14,920 | $33,080 | 69% |
| United Kingdom CARE Fertility · Bourn Hall | $18,375 | $29,625 | 62% |
| Spain IVI (Barcelona, Madrid) · Institut Marquès | $19,510 | $28,490 | 59% |
| Mexico Ingenes (Mexico City, Monterrey, Guadalajara) · InVitroTec | $20,500 | $27,500 | 57% |
Travel cost assumes flights + 7–10 days accommodation. Modern destination clinics typically offer remote monitoring via a local clinician to reduce trip count. Donor-egg programmes are a particular international draw: European waiting times are shorter and costs are materially lower than comparable US programmes.
5. What this means for patients
Three things are simultaneously true about US fertility care. Outcomes are among the world’s best — CDC-reporting US clinics achieve a cycle-weighted under-35 live birth rate of roughly 49% per intended retrieval. Pricing is among the most opaque — only 10% of clinics publish a base cycle price. Access is among the most inequitable — affordability ranges from ~25% of income in the cheapest mandate state to over 100% in the least affordable no-mandate state.
A patient in Massachusetts with a fully-insured large-group plan pays perhaps one-third of the cost a patient in Mississippi faces. Two patients of the same age with the same diagnosis and the same income face dramatically different odds of ever starting a family based on geography and their employer’s choice of health plan funding structure. This is not a market failure at the clinic level — clinical outcomes and capabilities are broadly comparable across the mandate and non-mandate markets. It is a policy choice, reinforced by a federal preemption most patients don’t know exists.
For journalists covering fertility, reproductive rights, health inequality, or employer benefit design, the state affordability table is a reusable hook. For patients, the practical implication is blunt: before committing to a clinic, confirm three things — whether your state mandate applies (look up the statute), whether your plan is self-insured (ask HR), and whether medical tourism or out-of-state access would produce better economics for the same treatment.
Methodology
Data sources:
- Clinic outcomes & cycle volumes: CDC National ART Surveillance System Final Summary 2022 (data.cdc.gov/resource/9tjt-seye)
- Clinic pricing: TreatCompare proprietary extraction from 455 US clinic websites (April 2026); 45 disclose base cycle pricing publicly
- Cycle and add-on price ranges: ASRM patient handouts; FertilityIQ patient-reported survey medians; clinic-published pricing where available
- State insurance mandates: state statute text; RESOLVE state coverage tracker
- Median household income: US Census Bureau, ACS 2022 5-Year Estimates (S1901)
- State cost-of-living index: MERIC Cost of Living Index, 2023 annual
- International pricing: published patient-facing ranges from prominent clinics in each market
Modelling assumptions. Where precise clinic-level data was unavailable, estimates were modelled using published ranges and cost-of-living adjustments. Specifically: state-level cycle cost is modelled as national median × (state COL / 100); medication and add-ons are treated as national (not state-varying); cycles-to-live-birth is fixed at 2.0 for the headline estimate (ASRM consumer guidance); out-of-pocket share by mandate type uses the assumptions in Section 2. The full affordability model and all inputs are open source at github.com/langdonpm/weightindex/tree/main/src/lib/us.
What this analysis is and isn’t. This is a modelled estimate for journalism and patient education, not a pricing guarantee. State medians conceal significant within-state variation; clinic-level variation exceeds state-level variation in every state with meaningful clinic diversity. Use the affordability ratio as a directional comparison across states, not as a predicted cost for any individual patient.